| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/20/2010 | CN100581587C Method for comprehensively producing and utilizing nanometer biological active material |
| 01/20/2010 | CN100581586C A rapid-acting pharmaceutical composition |
| 01/20/2010 | CN100581582C Compound oral taking preparation of cantharis, and preparation method |
| 01/20/2010 | CN100581581C Technique for preparing Chinese traditional medicine and pills for clearing away heart-fire, dispersing phlegm, tranquilizing the mind, and reducing blood pressure |
| 01/20/2010 | CN100581579C Medicinal composition for treating prostate disease and its preparation method and application |
| 01/20/2010 | CN100581578C Chinese traditional medicine capsule for healing neuropathic pain and preparing process technique thereof |
| 01/20/2010 | CN100581576C Medicine for treating nonunion of bone and method for preparing the same |
| 01/20/2010 | CN100581569C Production of drop-pill preparation in treatment of pelvic inflammatory disease |
| 01/20/2010 | CN100581568C Production of slow-releasing capsule in treatment of pelvic inflammatory disease |
| 01/20/2010 | CN100581566C Chinese medicine preparation for treating arrhythmia |
| 01/20/2010 | CN100581564C Yang-nourishing five-saponins medicine for preventing and curing cardiovascular or cerebrovascular disease, and the prepartion and the method for preparing the same |
| 01/20/2010 | CN100581563C Method for preparing compound pyrrosia leaf capsule |
| 01/20/2010 | CN100581562C Preparation method for separating and purifying extractive from lotus leaves, and usage |
| 01/20/2010 | CN100581561C Asiatic moonseed extract, preparations, preparing method and use thereof |
| 01/20/2010 | CN100581559C Compound orally disintegrating tablet of red sage root, its preparation method and detection method |
| 01/20/2010 | CN100581558C Preparation of blood-activating and pain-stopping capsules |
| 01/20/2010 | CN100581557C Chinese medicinal composition, its preparation and use in pharmacy |
| 01/20/2010 | CN100581555C Viable prebiotics bacteria microcapsule preparations for livestock and method for preparing the same |
| 01/20/2010 | CN100581554C Abalone shell calcium complement agent |
| 01/20/2010 | CN100581551C Utilization of phosphatidylserine in the treatment of attention deficit syndrome (ADHS) |
| 01/20/2010 | CN100581549C Sustained-release preparation containing hydrochlorothiazide and preparation method thereof |
| 01/20/2010 | CN100581548C Citric acid Mosabily oral liquid |
| 01/20/2010 | CN100581547C Ranolazine sustained release tablets |
| 01/20/2010 | CN100581546C Medicament compound containing milrinone |
| 01/20/2010 | CN100581545C Siromosi medicinal composition and its making method |
| 01/20/2010 | CN100581544C Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction |
| 01/20/2010 | CN100581540C Isosorbide mononitrate timing quick-release and slow-release preparation |
| 01/20/2010 | CN100581538C Magnetic slow releasing diclofenac sodium preparation in supermolecular intercalation structure and its preparation method |
| 01/20/2010 | CN100581502C Human soft tissue filler for injection, and its preparation method |
| 01/19/2010 | US7649097 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 01/19/2010 | US7649089 Biodegradable oxidized cellulose esters and their uses as microspheres |
| 01/19/2010 | US7649023 Using polyoxyethylene glycol solutions; mixing with drug |
| 01/19/2010 | US7649019 Modified release formulations of a bupropion salt |
| 01/19/2010 | US7648982 Inhaling formulation providing analgesia to patient; contains one rapid-onset opioid and a sustained-effect opioid; avoiding toxicity while achieving analgesia, side effect occurs before the onset of toxicity; dispensers |
| 01/19/2010 | US7648981 Opioid delivery system |
| 01/19/2010 | US7648976 Potential as an anticancer agent; an inhibitor of heat shock protein-90; superior for the preparation of dispersion-based pharmaceutical formulations |
| 01/19/2010 | US7648962 which retain activity for stimulating cyclic guanosine monophosphate production and binding to natriuretic peptide receptor type A; improved bioavailability and half-life in circulation; for treatment of congestive heart failure |
| 01/19/2010 | US7648960 Method for delivery of monomeric or dimeric insulin complexed to diketopiperazine microparticles |
| 01/19/2010 | US7648959 Methods and compositions for the treatment of diseases of the eye |
| 01/19/2010 | US7648739 Switchable surfaces |
| 01/19/2010 | US7648720 Dietary fiber delivery system |
| 01/19/2010 | US7648719 Method for oxygen treatment of unsaturated carbon compounds, novel epoxy-structured material obtained by the method, apparatus for carrying out the method and a therapeutic composition using the material |
| 01/19/2010 | US7648715 Colourants encapsulated in polymer matrix |
| 01/19/2010 | US7648713 Covalently crosslinked hydrogel having < equilibrium level of hydration for undergoing a volumetric expansion of >/= 50% and having a shape to occlude a lumen or void upon swelling |
| 01/19/2010 | US7648712 Fast dissolving orally consumable films containing a taste masking agent |
| 01/19/2010 | US7648710 Formulation containing phosphate derivatives of electron transfer agents |
| 01/19/2010 | US7648706 West nile DNA vaccine |
| 01/19/2010 | US7648705 Methods for prevention or amelioration of West Nile encephalitis using a West Nile DNA vaccine |
| 01/19/2010 | US7648702 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine. |
| 01/19/2010 | US7648696 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent |
| 01/19/2010 | US7648695 A halogenated xanthene derivative, preferably Rose Bengal; can be delivered at high concentrations to certain tissues |
| 01/19/2010 | US7648677 Method for operating a reservoir-based sensor device |
| 01/19/2010 | US7648496 Device and method for accurate delivery of an active agent |
| 01/19/2010 | US7648495 Apparatus for the delivery of drugs or gene therapy into a patient's vasculature and methods of use |
| 01/19/2010 | CA2671604A1 Medicament dosage for inhaler |
| 01/19/2010 | CA2544422C Soft steroid compositions for use in dry powder inhalers |
| 01/19/2010 | CA2537103C Once daily dosage forms of trospium |
| 01/19/2010 | CA2517001C Hemorrhoid treatment pad |
| 01/19/2010 | CA2480783C An improved modified release preparation |
| 01/19/2010 | CA2464243C Method and composition for dry eye treatment |
| 01/19/2010 | CA2392361C Gastroretentive controlled release pharmaceutical dosage forms |
| 01/19/2010 | CA2373255C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 01/19/2010 | CA2366911C Compositions for improving fertility |
| 01/19/2010 | CA2183620C Sustained release composition |
| 01/19/2010 | CA2164517C Method of treating retained pulmonary secretions |
| 01/17/2010 | CA2672278A1 Patch and patch preparation |
| 01/17/2010 | CA2672276A1 Patch and patch preparation |
| 01/15/2010 | CA2637977A1 Dosage form containing a statin |
| 01/14/2010 | WO2010006236A1 Delivery of dry formulations of octreotide |
| 01/14/2010 | WO2010006200A2 Triggered release of drugs from polymer particles |
| 01/14/2010 | WO2010006194A2 Non-covalent modification of microparticles and process of preparing same |
| 01/14/2010 | WO2010006143A2 Transdermal estrogen device and delivery |
| 01/14/2010 | WO2010005916A1 Rosorbable membrane implanting methods for reducing adhesions |
| 01/14/2010 | WO2010005770A2 Electrostatically charged nasal application multipurpose products and method |
| 01/14/2010 | WO2010005741A1 Nanogels for cellular delivery of therapeutics |
| 01/14/2010 | WO2010005740A2 Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles |
| 01/14/2010 | WO2010005732A2 Composition and method of preparation of release systems for constant (zero-order) release of active agents |
| 01/14/2010 | WO2010005726A2 Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same |
| 01/14/2010 | WO2010005725A2 Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same |
| 01/14/2010 | WO2010005723A2 Drug loaded polymeric nanoparticles and methods of making and using same |
| 01/14/2010 | WO2010005721A2 Drug loaded polymeric nanoparticles and methods of making and using same |
| 01/14/2010 | WO2010005637A2 Electrostatically charged multi-acting nasal application, product, and method |
| 01/14/2010 | WO2010005480A2 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 01/14/2010 | WO2010005403A1 Dermatological composition for use in the treatment and/or prevention of skin diseases |
| 01/14/2010 | WO2010005344A1 Nanosomal pharmaceutical form of a long acting preparation for treating hepatitis c (variants) |
| 01/14/2010 | WO2010005257A2 Controlled-release pharmaceutical preparation containing nicorandil |
| 01/14/2010 | WO2010005146A1 Tablet containing acanthopanax sessiliflorus and vitamin and method manufacturing thereof |
| 01/14/2010 | WO2010005133A1 Manufacturing method of collagen gel composition for bone regeneration |
| 01/14/2010 | WO2010004982A1 Ameliorating or therapeutic agent for dyslipidemia |
| 01/14/2010 | WO2010004594A1 Ophthalmic compositions for treating pathologies of the posterior segment of the eye |
| 01/14/2010 | WO2010004490A2 Electronic pill comprising a medicine reservoir |
| 01/14/2010 | WO2010004334A2 Exine shells |
| 01/14/2010 | WO2010004299A2 Composition |
| 01/14/2010 | WO2010004287A2 Process |
| 01/14/2010 | WO2010004022A1 Directly pressed aliskiren tablets |
| 01/14/2010 | WO2010004018A2 Degradable microcapsules |
| 01/14/2010 | WO2010003996A1 Eprosartan compositions |
| 01/14/2010 | WO2010003811A1 Amphiphilic proteins as morphology modifiers |
| 01/14/2010 | WO2010003645A1 Formulations with polycarbohydratesiloxane coatings, their production and use |
| 01/14/2010 | WO2010003641A1 Pharmaceutical compositions comprising 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |